A detailed history of Bill & Melinda Gates Foundation transactions in Exscientia PLC stock. As of the latest transaction made, Bill & Melinda Gates Foundation holds 1,590,909 shares of EXAI stock, worth $7.46 Million. This represents 17.85% of its overall portfolio holdings.

Number of Shares
1,590,909
Previous 1,590,909 -0.0%
Holding current value
$7.46 Million
Previous $8.11 Million 4.31%
% of portfolio
17.85%
Previous 20.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$17.63 - $27.1 $28 Million - $43.1 Million
1,590,909 New
1,590,909 $31.4 Million

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $574M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Bill & Melinda Gates Foundation Portfolio

Follow Bill & Melinda Gates Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill & Melinda Gates Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Bill & Melinda Gates Foundation with notifications on news.